Stockpolly
Search
BCYC · NASDAQ · Biotechnology

Bicycle Therapeutics (ADR) (BCYC)

Develops Bicycle Drug Conjugates and radioconjugates for precision oncology.

$4.30
At close+0.20 (+4.88%)
Watchlist

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue5520934103124811
Cost of revenue0000465657710000
Gross profit55209−43−52−47−68124811
566051562115231877736655
Research & development404535404850597158524941
161516161821211919211814
Selling & marketing000000000000
General & administrative161516161821211919211814
Other expenses1000−46−56−57−720000
Operating income−51−54−32−47−64−68−70−87−66−25−66−55
35571015877654
Interest income46681110877654
Interest expense111100000000
Other non-operating income−4−6−6−80−15−8−7−7−6−5−4
Income before tax−48−49−27−40−54−53−62−79−59−19−61−50
Income tax expense2000−3−1−100100
Net income from continuing operations−50−49−27−40−51−52−61−79−59−20−61−50
Other adjustments000000000000
Net income−50−49−27−40−51−52−61−79−59−20−61−50
EPS, basic−$1.26−$1.16−$0.62−$0.77−$0.74−$0.74−$0.88−$1.14−$0.85−$0.29−$0.87−$0.72
EPS, diluted−$1.26−$1.16−$0.62−$0.77−$0.74−$0.74−$0.88−$1.14−$0.85−$0.29−$0.87−$0.72
Weighted average shares, basic404243526969696969697070
Weighted average shares, diluted404243526969696969697070
EBITDA−45−46−24−37−61−51−60−77−57−17−59−49
Depreciation & amortization222222222111
EBIT−47−48−26−39−63−53−62−79−59−19−61−50